Interventions for tobacco use cessation in people living with HIV and AIDS

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 6, 2016, Pages

  Pool, Erica Rm ^a   Dogar, Omara ^b   Lindsay, Ryan P ^c   Weatherburn, Peter ^d   Siddiqi, Kamran ^e  

^a Worthing Hospital   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c IDAHO STATE UNIVERSITY   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC AGENT; VARENICLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING CESSATION; TIME FACTOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BEHAVIOR THERAPY; HIV INFECTIONS; HUMANS; NICOTINIC AGONISTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING CESSATION; TIME FACTORS; TOBACCO USE CESSATION; VARENICLINE;

EID: 84973524696     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011120.pub2     Document Type: Review

References (133)

1. Cropsey KL, Hendricks PS, Jardin B, Clark CB, Katiyar N, Willig J, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addictive Behaviors 2013;38(10):2541-6. [DOI: 10.1016/j.addbeh.2013.05.003]
2. Elzi L, Spoerl D, Voggensperger J, Nicca D, Simcock M, Bucher HC, et al. A smoking cessation programme in HIV-infected individuals: A pilot study. Antiviral Therapy 2006;11(6):787-95.
3. Browning KK, Wewers ME, Ferketich AK, Diaz P, Koletar SL, Reynolds NR. Adherence to tobacco dependence treatment among HIV-infected smokers. AIDS and Behaviour 2016;20(3):608-21.
4. Ferketich AK, Diaz P, Browning KK, Lu B, Koletar S, Reynolds N, et al. Safety of varenicline among HIV-infected smokers (POS3-115). Proceedings of the Society for Research on Nicotine and Tobacco's 18th Annual Meeting; 2012 Mar 13-16; Texas. 2012.
5. Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, et al. Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine & Tobacco Research 2013;15(1):247-54.
6. NCT00933595 . Longitudinal studies of HIV-associated lung infections and complications (Lung HIV). clinicaltrials.gov/show/NCT00933595 2009.
7. Humfleet G, Dilley J, Hall S, Delucchi K. Smoking cessation in HIV+ clinical care settings (SYM10D). Proceedings of the Society for Research on Nicotine and Tobacco's 17th Annual Meeting; 2011 Feb 16-19; Toronto (ON). 2011.
8. Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine & Tobacco Research 2013;15(8):1436-45.
9. Humfleet, G, Hall, S, Delucchi . K . Smoking cessation in HIV+ clinical care settings: participant characteristics. POS2-17. Society for Research on Nicotine and Tobacco's 14th Annual Meeting, USA.. 2008.
10. Humfleet, G, Hall, S, Delucchi, K, Dilley . J . Smoking cessation in HIV+ clinical care settings: preliminary findings. POS2-17. Society for Research on Nicotine and Tobacco's 15th Annual Meeting, Ireland. 2008.
11. NCT00297453 . Smoking treatment in HIV clinical care settings. clinicaltrials.gov/ct2/show/NCT00297453 2006.
12. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS & Behavior 2009;13(3):545-54. [DOI: 10.1007/s10461-007-9334-4]
13. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Betancourt RM, Stein M, Tashima K, et al. HIV-positive smokers considering quitting: differences by race/ethnicity. American Journal of Health Behavior 2008;32(1):3-15.
14. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction 2009;104(11):1891-900.
15. Niaura R, Stanton C, De Dios M, Tashima K. Socialization influences response to motivational enhancement for smoking cessation among HIV+ smokers (SYM10C). Proceedings of the Society For Research On Nicotine and Tobacco 17th Annual Meeting; 2011 Feb 16-19; Toronto (ON).
16. Niaura, R . Motivation and Patch Treatment for HIV-Positive Smokers (Positive PATHS). NCT00551720. ClinicalTrials.gov 2007.
17. Stanton C.A, Lloyd-Richardson E.E, Papandonatos G.D, de Dios, M. A, Niaura R. [Mediators of the relationship between nicotine replacement therapy and smoking abstinence among people living with HIV/AIDS. POS2-72]. Society for Research on Nicotine and Tobacco's 15th Annual Meeting, Ireland.. 2009.
18. Stanton CA, Lloyd-Richardson EE, Papandonatos GD, Niaura R. Smoking reduction among people living with HIV/AIDS: are there associations with short- term health outcomes? (POS5-111). Proceedings of the Society For Research On Nicotine and Tobacco 16th Annual Meeting; 2010 Feb 24-27; Baltimore (MD).
19. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care 2013;25(7):820-7. [DOI: 10.1080/09540121.2012.733331]
20. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. Journal of Acquired Immune Deficiency Syndromes: JAIDS 2012;61(2):208-15. [DOI: 10.1097/QAI.0b013e3182645679]
21. NCT01106638 . A trial to test the efficacy of a tailored intensive smoking cessation intervention in persons with HIV (PWHs). clinicaltrials.gov/ct2/show/NCT01106638 2010.
22. NCT01898195 . Improving adherence to smoking cessation medication among PLWHA (HIV). clinicaltrials.gov/ct2/show/NCT01898195 2013.
23. Shelley D, Tseng TY, Gonzalez M, Krebs P, Wong S, Furberg R, et al. Correlates of adherence to varenicline among hiv+ smokers: a path analysis. Nicotine & Tobacco Research 2015;17(8):968-74. [DOI: 10.1093/ntr/ntv068]
24. NCT01570595 . Positively smoke free on the Web (PSFW) for smokers living with HIV. clinicaltrials.gov/ct2/show/NCT01570595 2012.
25. Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes: JAIDS 2014;67(1):59-66.
26. NCT00503230 . Reducing ethnic health disparities: motivating HIV+ Latinos to quit smoking (AURORA). clinicaltrials.gov/ct2/show/NCT00503230.
27. Stanton CA, Bicki A, Gould H, Makgoeng S, Papandonatos GD, Shuter J, et al. Does a preference for menthol cigarettes impact smoking patterns and sustained abstinence among Latino smokers living with HIV? (POS3-75). Proceedings of the Society For Research On Nicotine and Tobacco 20th Annual Meeting; 2014 Feb 5-8; Seattle.
28. Stanton CA, Papandonatos GD, Shuter J, Bicki A, Lloyd-Richardson EE, De Dios MA, et al. Outcomes of a tailored intervention for cigarette smoking cessation among Latinos living with HIV/AIDS. Nicotine & Tobacco Research 2015;17(8):975-82.
29. Stanton CA, Papandonatos GD, Shuter J, Makgoeng S, Lloyd-Richardson EE, De Dios MA, et al. Project aurora: a culturally tailored intervention for cigarette smoking cessation among Latinos living with HIV/ AIDS (POS1-170). Proceedings of the Society for Research on Nicotine and Tobacco's 19th Annual Meeting; 2013 13-16; Boston.
30. Vidrine DJ, Arduino RC, Gritz ER. Impact of a cell phone intervention on mediating mechanisms of smoking cessation in individuals living with HIV/AIDS. Nicotine & Tobacco Research 2006;8(Suppl 1):S103-8.
31. Vidrine DJ, Arduino RC, Gritz ER. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care and STDS 2007;21(9):659-66.
32. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS 2006;20(2):253-60. [DOI: 10.1097/01.aids.0000198094.23691.58]
33. Vidrine DJ, Mehta NV, Gritz ER, Arduino RC. Effects of smoking cessation on symptom status among persons living with HIV/AIDS (POS1-104) Proceedings of the Society for Research on Nicotine and Tobacco's 13th Annual Meeting; 2007 Feb 21-24; Texas.
34. Gritz ER, Danysh HE, Fletcher FE, Tami-Maury I, Fingeret MC, King RM, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clinical Infectious Diseases 2013;57(4):608-15.
35. Gritz ER, Vidrine DJ, Marks RM, Arduino RC. A randomized trial of an innovative cell phone intervention for smokers living with HIV/AIDS (SYM10A). Proceedings of the Society for Research on Nicotine and Tobacco's 17th Annual Meeting; 2011 Feb 16-19; Toronto.
36. Gritz ER, Vidrine DJ, Marks RM, Danysh HE, Arduino RC. A cell phone-delivered intervention for HIV-positive smokers: project reach out (POS3-113). Proceedings of the Society for Research on Nicotine and Tobacco's 18th Annual Meeting; 2012 Mar 13-16; Houston. Society For Research On Nicotine and Tobacco's 18th Annual Meeting, USA.
37. NCT00502827 . Smoking cessation for HIV/AIDS patients. clinicaltrials.gov/ct2/show/NCT00502827 2007.
38. Tamí-Maury I, Vidrine D, Fletcher FE, Danysh H, Arduino R, Gritz ER. Impact of innovative smoking cessation interventions for hiv+ smokers who are multiple tobacco products users (POS2-113). Proceedings of the Society for Research on Nicotine and Tobacco's 19th Annual Meeting; 2013 Mar 13-16; Boston.
39. Tamí-Maury I, Vidrine DJ, Fletcher FE, Danysh H, Arduino R, Gritz ER. Poly-tobacco use among HIV-positive smokers: implications for smoking cessation efforts. Nicotine & Tobacco Research 2013;15(12):2100-6.
40. Vidrine DJ, Kypriotakis G, Li L, Arduino RC, Fletcher FE, Tamí-Maury I, et al. Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug and Alcohol Dependence 2015;1(147):76-80.
41. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine & Tobacco Research 2012;14(1):106-10.
42. Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. Journal of the Association of Nurses in AIDS Care 2000;11(6):37-44. [DOI: 10.1016/S1055-3290(06)60353-1]
43. Berg CJ, Nehl EJ, Wang X, Ding Y, He N, Johnson BA, et al. Healthcare provider intervention on smoking and quit attempts among HIV-positive versus HIV-negative MSM smokers in Chengdu, China. AIDS Care 2014;26(9):1201-7.
44. Browning KK, Wewers ME, Ferketich AK, Diaz P. Tobacco use and cessation in HIV-infected individuals. Clinics in Chest Medicine 2013;34(2):181-90.
45. Burkhalter JE, Corner G, Noy A, Lubetkin E, Guidry J, Kornegay M. Motivational respiratory biomarker feedback cessation intervention for low-income persons living with HIV/AIDS who smoke: intervention pre-testing results (POS2-164). Proceedings of the Society for Research on Nicotine and Tobacco's 19th Annual Meeting; 2013 Mar 13-16; Boston.
46. Burkhalter, J . Feasibility of Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations. NCT01482923.. ClinicalTrials.gov.
47. Chefitz AC. Literacy among HIV-infected persons referred to a web-based tobacco treatment trial (POS1-153). Proceedings of the Society for Research on Nicotine and Tobacco's 20th Annual Meeting; 2014 Feb 5-8; Seattle.
48. Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, et al. Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care and STDS 2012;26(1):12-9.
49. Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nursing Standard 2005;20(12):41-7.
50. Fuster M, Estrada V, Fernandez-Pinilla MC, Fuentes-Ferrer ME, Tellez MJ, Vergas J, et al. Smoking cessation in HIV patients: rate of success and associated factors. HIV Medicine 2009;10(10):614-9.
51. Huber M1, Ledergerber B, Sauter R, Young J, Fehr J, Cusini A, et al. Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Medicine 2012;13(7):387-97.
52. Lazev A, Vidrine D, Arduino R, Gritz E. Increasing access to smoking cessation treatment in a low-income, HIV-positive population: The feasibility of using cellular telephones. Nicotine & Tobacco Research 2004;6(2):281-6.
53. Lima EM, Gualandro DM, Yu PC, Giuliano Ide C, Marques AC, Calderaro D, et al. Cardiovascular prevention in HIV patients: results from a successful intervention program. Atherosclerosis 2009;204(1):229-32.
54. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care and STDS 2013;27(1):22-32.
55. McKie D. Assault on AIDS and smoking. Lancet 1985;14(8468):1371.
56. NCT00918307 . Efficacy and safety of varenicline among HIV-infected patients (Inter-ACTIV). clinicaltrials.gov/ct2/show/NCT00918307 2014.
57. NCT01393301 . Integrated treatment for smoking cessation & anxiety in people with HIV phase 1 (Project Quit). clinicaltrials.gov/ct2/show/NCT01393301.
58. NCT01436136 . Reducing cardiovascular disease (CVD) risk in HIV on antiretroviral therapy over 12 months. clinicaltrials.gov/ct2/show/NCT01436136.
59. NCT02029612 . An evidence based smoking cessation program for persons living with HIV/AIDS. clinicaltrials.gov/ct2/show/NCT02029612 2014.
60. Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, García-Rodríguez P, Soler A. Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy [Uso de bupropión en la deshabituación tabáquica en pacientes infectados por el VIH en tratamiento antirretroviral]. Enfermedades Infecciosas y Microbiología Clínica 2006;24(8):509-11.
61. Reynolds NR. Cigarette smoking and HIV: more evidence for action. AIDS Education and Prevention 2009;21(3 Suppl):106-21.
62. Shadel WG, Galvan F, Tucker JS. Improving nicotine patch adherence among HIV-positive Latino smokers (SYM14B). Proceedings of the Society for Research on Nicotine & Tobacco's 20th Annual Meeting; 2014 Feb 5-8; Seattle.
63. Shelley D, Krebs P, Tseng T-Y, Wong S, Wright D, Wolfe H. Formative evaluation of a text messaging intervention to promote cessation medication (POS3-174). Proceedings of the Society for Research on Nicotine and Tobacco's 20th Annual Meeting; 2014 Feb 5-8; Seattle.
64. Tornero C, Mafé C. Varenicline and antiretroviral therapy in patients with HIV. Journal of Acquired Immune Deficiency Syndromes 2009;52(2):656.
65. Zweibel MA, Hughes V. Smoking cessation program in one New York City clinic for people with HIV infection. Proceedings of the XVII International AIDS Conference; 2008 Aug 3-8; Mexico City. www.who.int/mediacentre/events/meetings/intl_aids_conference/en/.
66. Zwiebel MA, Hughes V. Smoking cessation efforts in one New York city HIV clinic. Journal of the Association of Nurses in AIDS Care 2010;21(1):11-5.
67. NCT00701896 . Smoking cessation using motivational therapy and varenicline. clinicaltrials.gov/ct2/show/results/NCT00701896 2008.
68. Grossman E, Shelley D, Braithwaite RS, Lobach I, Goffin A, Rogers E, et al. Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trial. Trials 2012;1(13):126.
69. NCT01484340 . A smoking cessation trial in HIV-infected patients in South Africa. clinicaltrials.gov/ct2/show/NCT01484340 2011.
70. NCT01710137 . Varenicline for nicotene dependence among those living with HIV/AIDS. clinicaltrials.gov/ct2/show/NCT01710137 2012.
71. NCT01800019 . The Canadian HIV Quit Smoking Trial: tackling the co-morbidities of depression and cardiovascular disease in HIV+ smokers. clinicaltrials.gov/ct2/show/NCT01800019 2013.
72. NCT01886924 . Computer MI for Tobacco Quitline engagement in smokers living with HIV (MI-HIV). clinicaltrials.gov/ct2/show/NCT01886924 2013.
73. NCT01965405 . Smoking cessation people living with HIV/AIDS. clinicaltrials.gov/ct2/show/NCT01965405 2013.
74. NCT02072772 . A trial of positively smoke free group therapy for HIV-infected smokers. clinicaltrials.gov/ct2/show/NCT02072772 2014.
75. NCT02190643 . Improving nicotine patch adherence among Latino HIV-positive smokers. clinicaltrials.gov/ct2/show/NCT02190643 2014.
76. NCT02302859 . Mobile Media-Rich Interactive Guideline System (MMRIGS) pilot study. clinicaltrials.gov/ct2/show/NCT02302859 2014.
77. NCT02432482 . A mobile intervention to promote cessation in HIV-infected smokers. clinicaltrials.gov/ct2/show/NCT02432482 2015.
78. NCT02460900 . Optimizing smoking cessation for people with HIV/AIDS who smoke. clinicaltrials.gov/ct2/show/NCT02460900 2015.
79. Abbud RA, Finegan CK, Guay LA, Rich EA. Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. The Journal of Infectious Diseases 1995;172(3):859-63.
80. Agency for Healthcare Research and Quality. Treating Tobacco Use and Dependence: 2008 Update. www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/index.html May 2008.
81. Aliyu MH, Weldeselasse H, August EM, Keith LG, Salihu HM. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine & Tobacco Research 2013;15(1):177-84.
82. Benard A, Bonnet F, Tessier JF, Fossoux H, Dupon M, Mercie P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care and STDs 2007;21(7):458-68.
83. Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Schoni-Affolter F, et al. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. American Journal of Epidemiology 2013;178(6):877-84.
84. Buchacz K, Baker RK, Palella FJ Jr, Chmiel JS, Lichtenstein KA, Novak RM, et al. HOPS Investigators. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS 2010;24(10):1549-59.
85. Calvo-Sánchez M, Perelló R, Pérez I, Mateo MG, Junyent M, Laguno M, et al. Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studies. HIV Medicine 2013;14(1):40-8.
86. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute 2005;97(6):425-32.
87. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013;382(9903):1525-33.
88. Ehren K, Hertenstein C, Kümmerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection 2014;42(1):135-40.
89. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. American Journal of Public Health 2006;96(6):1060-5.
90. Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, D'Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003;17(8):1179-93.
91. Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, Palfreeman A, et al. Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption. American Journal of Respiratory and Critical Care Medicine 2008;178(6):630-6.
92. McMaster University (developed by Evidence Prime, Inc.). GRADEproGDT: GRADEpro Guideline Development Tool [www.guidelinedevelopment.org]. Hamilton: McMaster University (developed by Evidence Prime, Inc.), 2015.
93. Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine & Tobacco Research 2004;6(1):71-7.
94. Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV+ smokers: a pilot test. AIDS Patient Care and STDS 2013;27(1):17-21.
95. Hartmann-Boyce J, Lancaster T, Stead L. Print-based self-help interventions for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD001118.pub3]
96. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected Individuals: a nationwide, population-based cohort study. Clinical Infectious Diseases 2013;56(5):727-34.
97. Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fatkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS 2015;29(2):221-9.
98. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; Vol. 327, issue 7414:557-60.
99. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
100. Horvath KJ, Eastman M, Prosser R, Goodroad B, Worthington L. Addressing smoking during medical visits: patients with human immunodeficiency virus. American Journal of Preventive Medicine 2012;43(5 Suppl 3):S214-21.
101. Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges. AIDS Education and Prevention 2009;21(3 Suppl):54-64.
102. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR, et al. INSIGHT SMART Study Group. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. American Journal of Public Health 2010;100(10):1896-903.
103. Marshal MP, Friedman MS, Stall R, King KM, Miles J, Gold MA, et al. Sexual orientation and adolescent substance use: a meta-analysis and methodological review. Addiction 2008;103(4):546-56.
104. May MT, Ingle SM, Costagliola D, Justice AC, De Wolf F, Cavassini M, et al. Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). International Journal of Epidemiology 2013 April 18 [Epub ahead of print]. [DOI: 10.1093/ije/dyt010]
105. Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. International Journal of Infectious Diseases 2005;9(4):208-17.
106. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.. PLoS Med 2009;6(7):e1000097.
107. Morris A, George MP, Crothers K, Huang L, Lucht L, Kessinger C, et al. HIV and chronic obstructive pulmonary disease: is it worse and why?. Proceedings of the American Thoracic Society 2011;8(3):320-5.
108. Moscou-Jackson G, Commodore-Mensah Y, Farley J, DiGiacomo M. Smoking-cessation interventions in people living with HIV infection: a systematic review. Journal of the Association of Nurses in AIDS Care 2014;25(1):32-45.
109. Munyati SS, Redzo N, Dauya E, Matambo R, Makamure B, Bandason T, et al. Human immunodeficiency virus, smoking and self-rated health in Harare, Zimbabwe. International Journal of Tuberculosis and Lung Disease 2006;10(11):1279-85.
110. Naif HM. Pathogenesis of HIV Infection. Infectious Disease Reports 2013;5(Suppl 1):e6.
111. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS 2012;26(3):335-43.
112. Nurutdinova D, Chrusciel T, Zeringue A, Scherrer JF, Al-Aly Z, McDonald JR, et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS 2012;26(2):229-34.
113. Palella FJ Jr, Phair JP. Cardiovascular disease in HIV infection. Current Opinion in HIV and AIDS 2011;6(4):266-71.
114. Petoumenos K, Worm S, Reiss P, de Wit S, D'Arminio Monforte A, Sabin C, et al. D:A:D Study Group. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Medicine 2011;12(7):412-21.
115. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
116. Reynolds NR, Neidig JL, Wewers ME. Illness representation and smoking behavior: a focus group study of HIV-positive men. Journal of the Association of Nurses in AIDS Care 2004;15(4):37-47.
117. Schadé A, Van Grootheest G, Smit JH. HIV-infected mental health patients: characteristics and comparison with HIV-infected patients from the general population and non-infected mental health patients. BMC Psychiatry 2013;13:35. [DOI: 10.1186/1471-244X-13-35]
118. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials.. PLoS Med 2010;7(3):e1000251.
119. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. American Journal of Health Behavior 2012;36(1):75-85.
120. Shuter J, Salmo LN, Shuter AD, Nivasch EC, Fazzari M, Moadel AB. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS and Behavior 2012;16(2):288-94.
121. Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, et al. HIV as an independent risk factor for incident lung cancer. AIDS 2012;26(8):1017-25.
122. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006;368(9534):489-504.
123. Sroussi HY, Villines D, Epstein J, Alves MC, Alves ME. Oral lesions in HIV-positive dental patients - one more argument for tobacco smoking cessation. Oral Diseases 2007;13(3):324-8.
124. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2012, Issue 11. [DOI: 10.1002/14651858.CD000146.pub4]
125. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD008286.pub3]
126. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD007253.pub3]
127. UNAIDS . Global Statistics. www.unaids.org/ 2015.
128. Valiathan R, Miguez MJ, Patel B, Arheart KL, Asthana D. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS ONE 2014;9(5):e97698.
129. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine 2013;14(4):195-207.
130. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population.. Addiction 2012;107(10):1847-56.
131. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; Vol. 100, issue 3:299-303.
132. Winstone TA, Man SF, Hull M, Montaner JS, Sin DD. Epidemic of lung cancer in patients with HIV infection. Chest 2013;143(2):305-14.
133. Pool ERM, Dogar O, Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database of Systematic Reviews 2014, Issue 5. [DOI: 10.1002/14651858.CD011120]